Experience
Veritone Announces Sale of Veritone One to Insignia for up to $104 Million
October 22, 2024
Cooley advised Veritone, a company building human-centered enterprise artificial intelligence (AI) solutions, on the sale of its media agency, Veritone One, to Insignia Capital Group.
Related contacts
Related Practices & Industries
RTZ Systems Announces Acquisition by CollabriOS Health
October 10, 2024
Cooley advised RTZ Systems, an information technology and services company, on its acquisition by CollabriOS Health, a new entity formed by Assured Healthcare Partners that brings together a suite of integrated technology infrastructure, including electronic health records, third-party administrator financial services, and care coordination solutions designed to help Programs of All-Inclusive Care for the Elderly (PACE) optimize workflows, streamline business processes and enhance overall center operations.
Related contacts
Cannae Holdings and KDSA Announce Majority Stake Acquisition in The Watkins Company
October 7, 2024
Cooley advised Cannae Holdings (NYSE: CNNE), an investment firm with stakes in restaurants, technology-enabled healthcare services, financial services and more, on its partnership with KDSA Investment Partners to acquire a majority stake in The Watkins Company, a 156-year-old American heritage brand renowned for its high-quality flavoring products.
Related contacts
Related Practices & Industries
PetIQ Announces Definitive Merger Agreement With Bansk Group Valued at Approximately $1.5 Billion
August 7, 2024
Cooley advised PetIQ (Nasdaq: PETQ), a leading pet medication, health and wellness company, on its definitive merger agreement with Bansk Group, pursuant to which Bansk Group will acquire all outstanding shares of PetIQ’s common stock for $31 per share in an all-cash transaction valued at approximately $1.5 billion.
Related contacts
Related Practices & Industries
Perceptive Advisors Enters Into Definitive Merger Agreement With Vapotherm
June 17, 2024
Cooley advised Perceptive Advisors, a top healthcare investment firm, and its affiliates, including Perceptive Discovery Fund, on its definitive merger agreement with Vapotherm, a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, and listed as VAPO on the over-the-counter quotation exchange (OTCQX).
Related contacts
Related Practices & Industries
Related news and events
Veritone Announces Sale of Veritone One to Insignia for up to $104 Million
Cannae Holdings and KDSA Announce Majority Stake Acquisition in The Watkins Company
Admissions and credentials
New York